Bioinformatics.org
[NEU MS in Bioinformatics]
Not logged in

Bioinformatics.org
Membership (37278+) Group hosting [?]

Careers
About bioinformatics
Bioinformatics training
Bioinformatics jobs

Research
All information groups
Online databases Online analysis tools Online education tools More tools

Development
All software groups
FTP repository
SVN & CVS repositories [?]
Mailing lists

Forums
News & Commentary
Jobs Forum
(Career Center)

Latest announcements
Submit Archive Subscribe
Submitter EXCERPT:
It's no secret that Google has broad ambitions in healthcare. But a document obtained by New Scientist reveals that the tech giant's collaboration with the UK's National Health Service goes far beyond what has been publicly announced.

The document -- a data-sharing agreement between Google-owned artificial intelligence company DeepMind and the Royal Free NHS Trust -- gives the clearest picture yet of what the company is doing and what sensitive data it now has access to.

The agreement gives DeepMind access to a wide range of healthcare data on the 1.6 million patients who pass through three London hospitals run by the Royal Free NHS Trust -- Barnet, Chase Farm and the Royal Free -- each year. This will include information about people who are HIV-positive, for instance, as well as details of drug overdoses and abortions. The agreement also includes access to patient data from the last five years.

SOURCE:
[link]

September 3, 2016, 9:00 - 17:00
The Hague, The Netherlands
World Forum, room: t.b.c.
[link]

Submit an abstract for ECCB 2016 workshop -- extended deadline 18th May

W2 -- Network Inference: New Methods and New Data

BACKGROUND:
Mammalian systems constitute over 200 cell types, each specialized to perform a distinct function, and yet all cell types share the same genome. This cell type specificity is achieved by a context-specific interpretation of the DNA sequence to produce a cell type specific transcription signature. Advances in sequencing techniques have accelerated the characterization of transcription landscapes across many normal and malignant cell types. The challenge now is to integrate these data to understand transcriptional control at a systems level. Over the years, powerful machine learning algorithms have been developed for inferring transcriptional networks from expression data, thereby revealing new aspects of complex biological systems.

AIMS AND SCOPE:
This one day SIG session will bring together experts from computational biology and machine learning to present recent advances in the development and application of gene regulatory network inference methods, as well as novel emerging single-cell and epigenomics data types suitable for network inference. The SIG will be split into two half day sessions. The first half will focus entirely on novel network inference methods, while the second half will focus on opportunities and challenges arising from new data types. Each session will feature an invited speaker and three short talks.

TARGET AUDIENCE:
The target audience is researchers working in the field of network inference or anyone who is working with large scale genome wide data. We expect typically 20 participants.

SUBMISSIONS:
Six talks will be selected by the organisers from submitted abstracts (max. 250 words). There will also be a 'hands-on' session with short pitches of new network inference tools or databases. Abstracts for both kinds of talks should be submitted online via the Easychair submission system: [link]. The deadline for submission is 18 May 2016.

Submitter EXCERPT:
The Health and Human Services Department is currently looking for small businesses who can help build that hub, so even researchers without informatics or genomics training can make "practical use" of data from cohort studies other scientists have already conducted.

GenPort's software and tools will be "open source, transportable, and freely shared," according to the HHS posting.

SOURCE:
[link]

Events: 4th Annual Immuno-Oncology Summit
Submitted by Heidi Ohrenberger; posted on Wednesday, April 13, 2016
August 29 - September 2, 2016
Boston, MA, USA
http://www.immuno-oncologysummit.com/

As our understanding of tumor immunology has advanced, immuno-oncology has made unprecedented progress in improving the outcomes for cancer patients. Still, with the field in its infancy, the full curative potential of IO has yet to be realized. CHI's 4th Annual Immuno-Oncology Summit has been designed to support a coordinated effort by industry players to bring commercial immunotherapies and immunotherapy combinations through clinical development and into the market. This weeklong, nine-meeting set will include topics ranging from early discovery through clinical development as well as emerging areas such as oncolytic virotherapy. Overall, this event will provide a focused look at how researchers are applying new science and technology in the development of the next generation of effective and safe immunotherapies.

Education: Bioinformatics Summer School in Angers, France
Submitted by Summer Schools; posted on Tuesday, April 12, 2016
Submitter 27th June - 8th July
Angers, France
[link]

"Dealing with big data and big models in biology : current challenges in bioinformatics"

The program developed in this Summer School aims at bringing students the ability to conduct ambitious biological studies from big data analysis to extract relevant biomarkers to large scale models engineering in order to enhance biological production. Topics to be covered include different fields of bioinformatics: data processing of genomic data, optimization methods in systems biology, statistics and classification for biomarker extraction, meta-genomics and a few more. Focus is also made on valorization concerns and technology transfer.

This program is ideal for those wishing to develop advanced skills in bioinformatics. Prior experience in computer science and computer programming is not required.

Resources: Prioritization of anticancer drugs
Submitted by Gajendra Raghava; posted on Monday, April 11, 2016
Submitter We are pleased to announce a new prediction server for the "prioritization of anticancer drugs against a cancer using genomic features".

ARTICLE:
http://www.nature.com/articles/srep23857

AVAILABILITY:
http://crdd.osdd.net/raghava/cancerdp/

July 9, 2016
Orlando, Florida, USA (ISMB SIG)
[link]
http://tare.medisin.ntnu.no/reggen/2016/

The RegGenSIG meeting focuses on bioinformatics for regulatory genomics, which involves the study of the genomic "control system", which determines how, when and where to activate the "blueprint" encoded in the genome. An important goal of the meeting is to foster a collaborative community wherein scientists convene to solve difficult research problems in all areas of computational regulatory genomics.

Call for abstracts - Oral presentations and poster presentations:

To make an oral presentation at RegGenSIG, a one-page abstract should be submitted by April 11, 2016, to Jason Ernst (jason.ernst[at]ucla.edu), with Subject: "RegGenSIG 2016 - Abstract for oral presentation", using the template found on the RegGenSIG web page, also attached to this email.

Based on the submitted abstracts, selected authors will be invited for oral presentation. Authors will be notified by May 2, 2016. Abstracts submitted for oral presentation may also be considered for poster presentation.

For poster presentations, authors should submit a one-page abstract no later than May 9, 2016, to Jason Ernst (jason.ernst[at]ucla.edu), with Subject: "RegGenSIG 2016 - Abstract for poster presentation", using the same template as for oral presentations. Author notification will occur no later than May 23, 2016.

Events: 8th Annual Next Generation Dx Summit
Submitted by Heidi Ohrenberger; posted on Monday, March 28, 2016
August 23-26, 2016
Washington, DC
http://www.nextgenerationdx.com/

Next Generation Dx Summit convenes more than 1,000 international diagnostic professionals for valuable networking and comprehensive programming spanning from clinical diagnostics to business strategy. Now in its eighth year, the event has grown to include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, commercialization, and reimbursement. New programming in 2016 includes prenatal diagnostics, circulating tumor cells, forensics, telemedicine and microbiome sequencing. The Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important issues for the industry.

Events: 8th Annual Bioprocessing Summit
Submitted by Heidi Ohrenberger; posted on Friday, March 25, 2016
August 15-19, 2016
Boston, MA, USA
http://www.bioprocessingsummit.com/

The Bioprocessing Summit brings together international leaders to discuss today's bioprocess issues from cell line selection to bioproduction. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer along the lively and cosmopolitan harbor waterfront. Each year, the international bioprocessing community comes together at the Summit to share practical solutions for today's bioprocess challenges with researchers from around the world. Spanning five days, the 2016 meeting includes 16 conference programs, 9 training seminars, and 10 short courses.

Events: 2016 Galaxy Community Conference (GCC2016)
Submitted by Dave Clements; posted on Tuesday, March 15, 2016 (1 comment)
Submitter June 25-29, 2016
Indiana University, Bloomington, Indiana, USA
http://gcc2016.iu.edu/

The 2016 Galaxy Community Conference (GCC2016, gcc2016.iu.edu) features two days of presentations, discussions, poster sessions, lightning talks, computer demos, keynotes, and birds-of-a-feather meet-ups, all about data-intensive biology and the tools that support it. Keynote speaker Yoav Gilad, a professor of human genetics at the University of Chicago, will kick-start the main conference with a discussion on the analysis of large gene regulatory data sets. Preconference events include data and coding hackathons, and two days of training in five concurrent tracks covering 26 topics.

GCC2016 will be held at Indiana University in Bloomington, Indiana, June 25-29, 2016. Since it started seven years ago, GCC has been a well-attended gathering of biologists, genome researchers, bioinformaticians, and others in data-intensive biomedical research around the world.

Galaxy is an open, web-based platform for data-intensive biomedical research and enables easy interactive analysis through the web on arbitrarily large data sets. The Galaxy framework is a major resource in achieving key research goals within the biological field. It provides next-generation sequencing (NGS) tools and workflows for short-read mapping, ChIP-seq, RNA-seq, metagenomics, variant analysis, visualization, and support for Galaxy in the cloud. There are hundreds of local installs, and over 80 publicly accessible servers around the world.

IMPORTANT DATES:
Abstract submission for oral presentations closes March 25.
Abstract submission for posters and computer demonstrations closes May 20.

REGISTRATION:
Early registration is now open. Registration starts at less than $45/day for post-docs and students. Registering early assures you a place at the conference and also a spot in the training workshops you want to attend. You can also book conference housing when you register. Registration and lodging scholarships are available for attendees from underrepresented groups and developing countries.

Submit Archive Subscribe
 
Acknowledgments

We wish to thank the following for their support:

[NEU MS in Bioinformatics]
[Bio-IT World]
[Become a sponsor]

 

Copyright © 2016 · Scilico, LLC